BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 15306578)

  • 1. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
    Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
    Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
    J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of
    Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
    Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
    Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
    Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
    J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
    Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
    PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
    Sung JJ; Lin SR; Ching JY; Zhou LY; To KF; Wang RT; Leung WK; Ng EK; Lau JY; Lee YT; Yeung CK; Chao W; Chung SC
    Gastroenterology; 2000 Jul; 119(1):7-14. PubMed ID: 10889149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer.
    Watari J; Tanaka A; Tanabe H; Sato R; Moriichi K; Zaky A; Okamoto K; Maemoto A; Fujiya M; Ashida T; Das KM; Kohgo Y
    J Clin Pathol; 2007 Aug; 60(8):921-6. PubMed ID: 16997920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
    Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia.
    Watari J; Das KK; Amenta PS; Tanabe H; Tanaka A; Geng X; Lin JJ; Kohgo Y; Das KM
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):409-17. PubMed ID: 18321787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study.
    Kyzekova J; Mour J
    Hepatogastroenterology; 1999; 46(27):2048-56. PubMed ID: 10430396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
    Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
    Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
    Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
    Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.